Nicolas Chatron1, Rikke S Møller2, Neena L Champaigne3, Amy L Schneider4, Alma Kuechler5, Audrey Labalme1, Thomas Simonet6, Lauren Baggett3, Claire Bardel7, Erik-Jan Kamsteeg8, Rolph Pfundt8, Corrado Romano9, Johan Aronsson10, Antonino Alberti9, Mirella Vinci9, Maria J Miranda11, Amy Lacroix12, Dragan Marjanovic2, Vincent des Portes13, Patrick Edery1, Dagmar Wieczorek5,14, Elena Gardella2, Ingrid E Scheffer4,15,16, Heather Mefford12, Damien Sanlaville1, Gemma L Carvill17, Gaetan Lesca1. 1. Department of Medical Genetics, Lyon University Hospital and GENDEV team CNRS UMR 5292, INSERM U1028, CRNL, and University Claude Bernard Lyon 1, GHE, Lyon, France. 2. Danish Epilepsy Centre, Dianalund, and University of Southern Denmark, Institute for Regional Health research, Odense, Denmark. 3. Greenwood Genetic Center, Greenwood, SC. 4. Epilepsy Research Centre, Department of Medicine, Austin Health, University of Melbourne, Heidelberg, VIC, Australia. 5. Institut für Humangenetik, Universitätsklinikum, and Universität Duisburg-Essen, Essen, Germany. 6. Service de Biostatistique-Bioinformatique, Lyon University Hospital, Lyon and CNRS UMR5558, Laboratoire de Biométrie et Biologie Evolutive, Equipe Biostatistique Santé, Villeurbanne, and University Claude Bernard Lyon 1, Lyon, France. 7. Centre de Biotechnologie Cellulaire, Hospices Civils de Lyon, Lyon, and Nerve-Muscle Interactions Team, Institut NeuroMyoGène CNRS UMR 5310-INSERM U1217-Université Claude Bernard Lyon 1, Lyon, France. 8. Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands. 9. Oasi Research Institute-IRCCS, Troina, Italy. 10. Habiliteringscentrum, Ryhov Hospital, Jönköping, Sweden. 11. Department of Pediatrics, Pediatric Neurology, Herlev University Hospital, Copenhagen, Denmark. 12. Department of Pediatrics, Division of Genetic Medicine, University of Washington, Seattle, WA. 13. Centre de référence « Déficiences Intellectuelles de causes rares », HCL, F-69675, Bron; ISC, CNRS UMR 5304, Bron; Université de Lyon, Lyon, France. 14. Institut für Humangenetik, Universitätsklinikum Essen, Essen, and Institut für Humangenetik, Universitätsklinikum Düsseldorf, Düsseldorf, Germany. 15. Florey Institute of Neuroscience and Mental Health, The University of Melbourne, VIC, Australia. 16. Department of Paediatrics, Royal Children's Hospital, The University of Melbourne, Parkville, Victoria, Australia. 17. Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL.
Abstract
OBJECTIVE: Cut homeodomain transcription factor CUX2 plays an important role in dendrite branching, spine development, and synapse formation in layer II to III neurons of the cerebral cortex. We identify a recurrent de novo CUX2 p.Glu590Lys as a novel genetic cause for developmental and epileptic encephalopathy (DEE). METHODS: The de novo p.Glu590Lys variant was identified by whole-exome sequencing (n = 5) or targeted gene panel (n = 4). We performed electroclinical and imaging phenotyping on all patients. RESULTS: The cohort comprised 7 males and 2 females. Mean age at study was 13 years (0.5-21.0). Median age at seizure onset was 6 months (2 months to 9 years). Seizure types at onset were myoclonic, atypical absence with myoclonic components, and focal seizures. Epileptiform activity on electroencephalogram was seen in 8 cases: generalized polyspike-wave (6) or multifocal discharges (2). Seizures were drug resistant in 7 or controlled with valproate (2). Six patients had a DEE: myoclonic DEE (3), Lennox-Gastaut syndrome (2), and West syndrome (1). Two had a static encephalopathy and genetic generalized epilepsy, including absence epilepsy in 1. One infant had multifocal epilepsy. Eight had severe cognitive impairment, with autistic features in 6. The p.Glu590Lys variant affects a highly conserved glutamine residue in the CUT domain predicted to interfere with CUX2 binding to DNA targets during neuronal development. INTERPRETATION: Patients with CUX2 p.Glu590Lys display a distinctive phenotypic spectrum, which is predominantly generalized epilepsy, with infantile-onset myoclonic DEE at the severe end and generalized epilepsy with severe static developmental encephalopathy at the milder end of the spectrum. Ann Neurol 2018;83:926-934.
OBJECTIVE:Cut homeodomain transcription factor CUX2 plays an important role in dendrite branching, spine development, and synapse formation in layer II to III neurons of the cerebral cortex. We identify a recurrent de novo CUX2p.Glu590Lys as a novel genetic cause for developmental and epilepticencephalopathy (DEE). METHODS: The de novo p.Glu590Lys variant was identified by whole-exome sequencing (n = 5) or targeted gene panel (n = 4). We performed electroclinical and imaging phenotyping on all patients. RESULTS: The cohort comprised 7 males and 2 females. Mean age at study was 13 years (0.5-21.0). Median age at seizure onset was 6 months (2 months to 9 years). Seizure types at onset were myoclonic, atypical absence with myoclonic components, and focal seizures. Epileptiform activity on electroencephalogram was seen in 8 cases: generalized polyspike-wave (6) or multifocal discharges (2). Seizures were drug resistant in 7 or controlled with valproate (2). Six patients had a DEE: myoclonic DEE (3), Lennox-Gastaut syndrome (2), and West syndrome (1). Two had a static encephalopathy and genetic generalized epilepsy, including absence epilepsy in 1. One infant had multifocal epilepsy. Eight had severe cognitive impairment, with autistic features in 6. The p.Glu590Lys variant affects a highly conserved glutamine residue in the CUT domain predicted to interfere with CUX2 binding to DNA targets during neuronal development. INTERPRETATION:Patients with CUX2p.Glu590Lys display a distinctive phenotypic spectrum, which is predominantly generalized epilepsy, with infantile-onset myoclonic DEE at the severe end and generalized epilepsy with severe static developmental encephalopathy at the milder end of the spectrum. Ann Neurol 2018;83:926-934.
Authors: Fadi F Hamdan; Candace T Myers; Patrick Cossette; Philippe Lemay; Dan Spiegelman; Alexandre Dionne Laporte; Christina Nassif; Ousmane Diallo; Jean Monlong; Maxime Cadieux-Dion; Sylvia Dobrzeniecka; Caroline Meloche; Kyle Retterer; Megan T Cho; Jill A Rosenfeld; Weimin Bi; Christine Massicotte; Marguerite Miguet; Ledia Brunga; Brigid M Regan; Kelly Mo; Cory Tam; Amy Schneider; Georgie Hollingsworth; David R FitzPatrick; Alan Donaldson; Natalie Canham; Edward Blair; Bronwyn Kerr; Andrew E Fry; Rhys H Thomas; Joss Shelagh; Jane A Hurst; Helen Brittain; Moira Blyth; Robert Roger Lebel; Erica H Gerkes; Laura Davis-Keppen; Quinn Stein; Wendy K Chung; Sara J Dorison; Paul J Benke; Emily Fassi; Nicole Corsten-Janssen; Erik-Jan Kamsteeg; Frederic T Mau-Them; Ange-Line Bruel; Alain Verloes; Katrin Õunap; Monica H Wojcik; Dara V F Albert; Sunita Venkateswaran; Tyson Ware; Dean Jones; Yu-Chi Liu; Shekeeb S Mohammad; Peyman Bizargity; Carlos A Bacino; Vincenzo Leuzzi; Simone Martinelli; Bruno Dallapiccola; Marco Tartaglia; Lubov Blumkin; Klaas J Wierenga; Gabriela Purcarin; James J O'Byrne; Sylvia Stockler; Anna Lehman; Boris Keren; Marie-Christine Nougues; Cyril Mignot; Stéphane Auvin; Caroline Nava; Susan M Hiatt; Martina Bebin; Yunru Shao; Fernando Scaglia; Seema R Lalani; Richard E Frye; Imad T Jarjour; Stéphanie Jacques; Renee-Myriam Boucher; Emilie Riou; Myriam Srour; Lionel Carmant; Anne Lortie; Philippe Major; Paola Diadori; François Dubeau; Guy D'Anjou; Guillaume Bourque; Samuel F Berkovic; Lynette G Sadleir; Philippe M Campeau; Zoha Kibar; Ronald G Lafrenière; Simon L Girard; Saadet Mercimek-Mahmutoglu; Cyrus Boelman; Guy A Rouleau; Ingrid E Scheffer; Heather C Mefford; Danielle M Andrade; Elsa Rossignol; Berge A Minassian; Jacques L Michaud Journal: Am J Hum Genet Date: 2017-11-02 Impact factor: 11.025
Authors: Madeleine R Geisheker; Gabriel Heymann; Tianyun Wang; Bradley P Coe; Tychele N Turner; Holly A F Stessman; Kendra Hoekzema; Malin Kvarnung; Marie Shaw; Kathryn Friend; Jan Liebelt; Christopher Barnett; Elizabeth M Thompson; Eric Haan; Hui Guo; Britt-Marie Anderlid; Ann Nordgren; Anna Lindstrand; Geert Vandeweyer; Antonino Alberti; Emanuela Avola; Mirella Vinci; Stefania Giusto; Tiziano Pramparo; Karen Pierce; Srinivasa Nalabolu; Jacob J Michaelson; Zdenek Sedlacek; Gijs W E Santen; Hilde Peeters; Hakon Hakonarson; Eric Courchesne; Corrado Romano; R Frank Kooy; Raphael A Bernier; Magnus Nordenskjöld; Jozef Gecz; Kun Xia; Larry S Zweifel; Evan E Eichler Journal: Nat Neurosci Date: 2017-06-19 Impact factor: 24.884
Authors: Beatriz Cubelos; Alvaro Sebastián-Serrano; Seonhee Kim; Juan Miguel Redondo; Christopher Walsh; Marta Nieto Journal: Dev Neurobiol Date: 2008-06 Impact factor: 3.964
Authors: Lawrence A Kelley; Stefans Mezulis; Christopher M Yates; Mark N Wass; Michael J E Sternberg Journal: Nat Protoc Date: 2015-05-07 Impact factor: 13.491
Authors: Andrew S Allen; Samuel F Berkovic; Patrick Cossette; Norman Delanty; Dennis Dlugos; Evan E Eichler; Michael P Epstein; Tracy Glauser; David B Goldstein; Yujun Han; Erin L Heinzen; Yuki Hitomi; Katherine B Howell; Michael R Johnson; Ruben Kuzniecky; Daniel H Lowenstein; Yi-Fan Lu; Maura R Z Madou; Anthony G Marson; Heather C Mefford; Sahar Esmaeeli Nieh; Terence J O'Brien; Ruth Ottman; Slavé Petrovski; Annapurna Poduri; Elizabeth K Ruzzo; Ingrid E Scheffer; Elliott H Sherr; Christopher J Yuskaitis; Bassel Abou-Khalil; Brian K Alldredge; Jocelyn F Bautista; Samuel F Berkovic; Alex Boro; Gregory D Cascino; Damian Consalvo; Patricia Crumrine; Orrin Devinsky; Dennis Dlugos; Michael P Epstein; Miguel Fiol; Nathan B Fountain; Jacqueline French; Daniel Friedman; Eric B Geller; Tracy Glauser; Simon Glynn; Sheryl R Haut; Jean Hayward; Sandra L Helmers; Sucheta Joshi; Andres Kanner; Heidi E Kirsch; Robert C Knowlton; Eric H Kossoff; Rachel Kuperman; Ruben Kuzniecky; Daniel H Lowenstein; Shannon M McGuire; Paul V Motika; Edward J Novotny; Ruth Ottman; Juliann M Paolicchi; Jack M Parent; Kristen Park; Annapurna Poduri; Ingrid E Scheffer; Renée A Shellhaas; Elliott H Sherr; Jerry J Shih; Rani Singh; Joseph Sirven; Michael C Smith; Joseph Sullivan; Liu Lin Thio; Anu Venkat; Eileen P G Vining; Gretchen K Von Allmen; Judith L Weisenberg; Peter Widdess-Walsh; Melodie R Winawer Journal: Nature Date: 2013-08-11 Impact factor: 49.962
Authors: Karen M J Van Loo; Gemma L Carvill; Albert J Becker; Karen Conboy; Alica M Goldman; Katja Kobow; Iscia Lopes-Cendes; Christopher A Reid; Erwin A van Vliet; David C Henshall Journal: Nat Rev Neurol Date: 2022-07-20 Impact factor: 44.711
Authors: Veronica Astro; Maryam Alowaysi; Elisabetta Fiacco; Alfonso Saera-Vila; Kelly J Cardona-Londoño; Riccardo Aiese Cigliano; Antonio Adamo Journal: Front Cell Dev Biol Date: 2022-02-03
Authors: Sterre van der Veen; Rodi Zutt; Christine Klein; Connie Marras; Samuel F Berkovic; John N Caviness; Hiroshi Shibasaki; Tom J de Koning; Marina A J Tijssen Journal: Mov Disord Date: 2019-10-04 Impact factor: 10.338